Proof of Concept Study to Evaluate Safety and Efficacy of LME636 in the Treatment of Acute Anterior Uveitis

NCT02482129 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Anterior Uveitis

Interventions

DRUG: LME636 60 mg/mL ophthalmic solution
DRUG: Dexamethasone 0.1% ophthalmic solution
DRUG: LME636 Vehicle

Sponsor

Alcon Research